1. Canada Stocks

  2. •

    Health technology

  3. •

    Medical specialties
IMRIS INC

IMRIS INC

OOTC:IMRSQ
0.00
USD
0.00
(0.00%)
-0.58EPS
IMRIS INC
OTC:IMRSQ
(OTC Markets)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2006
2007
2008
2009
2010
2011
2012
2013
2014
TTM
USD
0.3
0.9
0.69
1.52
2.07
1.16
1.14
0.91
0.55
0.55
Revenue per Share
-0.55
-0.75
-0.51
-0.31
-0.05
-0.47
-0.61
-0.83
-0.58
-0.58
Basic EPS, GAAP
-0.24
-0.85
-0.36
-0.37
-0.47
-0.48
-0.45
-0.99
-0.26
-0.26
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.21
1.38
0.63
0.98
2.11
1.66
1.1
0.76
0.19
0.19
Book Value per Share
- -
1.12
0.43
0.76
1.7
1.27
0.74
0.42
-0.04
-0.04
Tangible Book Value per Share
12
20
27
28
34
45
46
51
52
52
Basic Weighted Avg Shares
4
18
19
42
70
52
52
46
29
29
Sales/Revenue/Turnover
-180.09
-84.31
-81.66
-16.01
-1.4
-39.71
-52.53
-85.37
-80.09
-80.09
Operating Margin (%)
1
1
1
2
4
4
4
3
3
3
Depreciation Expense
-7
-15
-14
-9
-2
-21
-28
-42
-30
-30
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-184.84
-83.52
-73.9
-20.63
-2.51
-40.4
-52.98
-91.22
-105.18
-105.18
Profit Margin (%)
-2
28
6
16
54
33
25
25
3
3
Working Capital
- -
- -
- -
- -
- -
- -
- -
21
21
21
LT Debt
6
38
17
30
93
75
51
35
12
12
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-67.65
-50.81
-36.73
-2.86
-24.98
-44.36
-98.12
-129.83
-129.83
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Jun'14
Sep'14
Dec'14
ST Debt
2
2
2
LT Borrowings
22
21
21
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
52
52
63
Market Capitalization
- -
- -
- -

Working Capital

USD

•

in mil. unless spec.
Jun'14
Sep'14
Dec'14
Total Current Assets
37
28
35
Cash, Cash Equivalents & STI
3
4
5
Accounts Receivable, Net
6
4
9
Inventories
9
9
9
Total Current Liabilities
26
23
32
Payables & Accruals
10
10
13
ST Debt
2
2
2
Deferred Revenue
14
10
16

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
11.3%
-66.33%
Free Cash Flow
- -
30.91%
-72.87%
Net Income, GAAP
- -
212.28%
-27.65%
Sales/Revenue/Turnover
- -
-1.77%
-37.25%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2012
3
17
12
20
52
2013
8
10
18
10
46
2014
8
4
7
10
29

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2012
-0.18
-0.09
-0.19
-0.14
-0.61
2013
-0.18
-0.16
-0.07
-0.47
-0.83
2014
-0.15
-0.14
-0.16
-0.13
-0.58

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2012
- -
- -
- -
- -
- -
2013
- -
- -
- -
- -
- -
2014
- -
- -
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
IMRIS Inc. (IMRSQ) designs, manufactures, and services proprietary intraoperative MRI suites and image-guided therapy solutions for neurosurgery and interventional procedures in hospitals and cancer centers worldwide; its core offerings include the VISIUS Surgical Theatre and InVision Operating Suite featuring the world's only ceiling-mounted, movable iMRI system that glides between diagnostic and operating rooms on rails, enabling imaging without patient repositioning, alongside proprietary head fixation devices, imaging coils, OR tables, and comprehensive installation, renovation, and maintenance services for hybrid surgical environments. Founded in 2005 and headquartered in Chaska, Minnesota, with original roots in Winnipeg, Canada, the company serves over 100 global customers across neurosurgical, spinal, cerebrovascular, and cardiovascular markets, empowering minimally invasive procedures that have benefited over 70,000 patients by enhancing precision, reducing follow-up surgeries, and eliminating post-operative confirmatory scans. In February 2025, IMRIS was acquired by Grovecourt Capital Partners, a West Palm Beach, Florida-based private equity firm focused on healthcare services, marking a strategic shift to accelerate growth, product expansion into emerging applications like laser ablation and high-intensity focused ultrasound, and innovation under new ownership backed by financing from Ocean Avenue Capital Partners, Bell Capital Finance, and Farragut Capital Partners.

Company News

Company News APIChatGPT

  • defenseworld.net

    Financial Contrast: Imris (OTCMKTS:IMRSQ) versus Precision Optics (NASDAQ:POCI)